MedPath

Management of Generalised Anxiety Disorder with Shirodhara and Sarvanga Abhyanga

Phase 3
Conditions
Health Condition 1: F411- Generalized anxiety disorder
Registration Number
CTRI/2022/09/045565
Lead Sponsor
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Post Covid Patients

2 Patients with symptoms of Generalised Anxiety Disorder

3 Hypertensive Patients

Exclusion Criteria

1 Patients having serious systemic diseases like cardiac, renal or respiratory

2 Patients unsuitable for Shirodhara and Abhyanga

3 Patients taking any other treatment of Generalised Anxiety Disorder

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Subjective Criteria <br/ ><br>Hamilton Anxiety Rating ScaleTimepoint: 21 Days
Secondary Outcome Measures
NameTimeMethod
To find out the efficacy of treatment in 30 patients with the help of Hamilton Anxiety Rating ScaleTimepoint: 21 Days
© Copyright 2025. All Rights Reserved by MedPath